scholarly article | Q13442814 |
P50 | author | Richard Webby | Q89595126 |
Elena Govorkova | Q89851432 | ||
Jeremy C Jones | Q90689818 | ||
P2093 | author name string | Stephen W White | |
Gyanendra Kumar | |||
Subrata Barman | |||
Isabel Najera | |||
P2860 | cites work | Crystal structure of an avian influenza polymerase PA(N) reveals an endonuclease active site | Q27653656 |
The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit | Q27653657 | ||
Structural and Biochemical Basis for Development of Influenza Virus Inhibitors Targeting the PA Endonuclease | Q27671357 | ||
Structural Analysis of Specific Metal Chelating Inhibitor Binding to the Endonuclease Domain of Influenza pH1N1 (2009) Polymerase | Q27671365 | ||
HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes | Q27860502 | ||
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design | Q28071809 | ||
Mutational analysis of the binding pockets of the diketo acid inhibitor L-742,001 in the influenza virus PA endonuclease | Q28534627 | ||
Phaser.MRage: automated molecular replacement | Q28661765 | ||
A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro | Q30390167 | ||
Antivirals for pandemic influenza | Q30427953 | ||
Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en | Q35857200 | ||
Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor. | Q36770792 | ||
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season | Q37164761 | ||
In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. | Q37392896 | ||
Single PA mutation as a high yield determinant of avian influenza vaccines | Q37584477 | ||
The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses | Q38963385 | ||
PA subunit of RNA polymerase as a promising target for anti-influenza virus agents | Q40015466 | ||
Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets. | Q40333849 | ||
Eight-plasmid system for rapid generation of influenza virus vaccines | Q40712787 | ||
In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir | Q40911739 | ||
Mutational and metal binding analysis of the endonuclease domain of the influenza virus polymerase PA subunit | Q42428242 | ||
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States | Q45118572 | ||
In vivo Selection of an Influenza A2 Strain resistant to Amantadine | Q71478276 | ||
P2507 | corrigendum / erratum | Author Correction for Jones et al., "Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors" | Q59132664 |
P433 | issue | 2 | |
P577 | publication date | 2018-04-24 | |
P1433 | published in | mBio | Q15817061 |
P1476 | title | Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors. | |
P478 | volume | 9 |
Q64239050 | Q64239050 |
Q64136457 | A Step Forward in the Treatment of Influenza |
Q93028017 | Advances in respiratory virus therapeutics - A meeting report from the 6th isirv Antiviral Group conference |
Q90689822 | Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility |
Q63976719 | Influenza virus polymerase inhibitors in clinical development |
Q64065291 | Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil |
Q90736243 | Key Role of the Influenza A Virus PA Gene Segment in the Emergence of Pandemic Viruses |
Q89843860 | Next-generation direct-acting influenza therapeutics |
Q66679577 | Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections |
Q60046097 | Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil |
Search more.